Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' OHE Y' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 87 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ohe, Y; Yamamoto, S; Suzuki, K; Hojo, F; Kakinuma, R; Matsumoto, T; Ohmatsu, H; Nishiwaki, Y
      Risk factors of treatment-related death in chemotherapy and thoracic radiotherapy for lung cancer

      EUROPEAN JOURNAL OF CANCER
    2. Ishizaka, M; Ohe, Y; Senbongi, T; Wakabayashi, K; Ishikawa, K
      Inflammatory stimuli increase prostaglandin D synthase levels in cerebrospinal fluid of rats

      NEUROREPORT
    3. Tatsumi, Y; Arioka, H; Ikeda, S; Fukumoto, H; Miyamoto, K; Fukuoka, K; Ohe, Y; Saijo, N; Nishio, K
      Enhancement of in vivo antitumor activity of a novel antimitotic 1-phenylpropenone derivative, AM-132, by tumor necrosis factor-alpha or interleukin-6

      JAPANESE JOURNAL OF CANCER RESEARCH
    4. Kurata, T; Tamura, T; Shinkai, T; Ohe, Y; Kunitoh, H; Kodama, T; Kakinuma, R; Matsumoto, T; Kubota, K; Omatsu, H; Nishiwaki, Y; Saijo, N
      Phase I and pharmacological study of paclitaxel given over 3 h with cisplatin for advanced non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    5. Ohe, Y; Niho, S; Kakinuma, R; Kubota, K; Matsumoto, T; Ohmatsu, H; Goto, K; Kunitoh, H; Saijo, N; Nishiwaki, Y
      Phase I studies of cisplatin and docetaxel administered by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    6. Akiyama, Y; Ohe, Y; Tamura, T; Sawada, M; Inoue, A; Kusaba, H; Yamamoto, N; Sekine, I; Kunitoh, H; Kodama, T; Saijo, N
      A dose escalation study of paclitaxel and carboplatin in untreated Japanese patients with advanced non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    7. Tsuchiya, S; Ohe, Y; Sugiura, T; Fuwa, N; Kitamoto, Y; Mori, K; Kobayashi, H; Nakata, K; Sawa, T; Hirai, K; Etoh, T; Saka, H; Saito, A; Fukuda, H; Ishizuka, N; Saijo, N
      Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601)

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    8. Kunitoh, H; Akiyama, Y; Kusaba, H; Yamamoto, N; Sekine, I; Ohe, Y; Kubota, K; Tamura, T; Shinkai, T; Kodama, T; Goto, K; Niho, S; Nishiwaki, Y; Saijo, N
      A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer

      LUNG CANCER
    9. Usuda, J; Okunaka, T; Furukawa, K; Tsuchida, T; Kuroiwa, Y; Ohe, Y; Saijo, N; Nishio, K; Konaka, C; Kato, H
      Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis

      INTERNATIONAL JOURNAL OF CANCER
    10. Ohe, Y; Ichimura, K
      Positive-working photoresists containing tetrahydropyranyl group as an acid-labile polymer for rainbow holograms

      JOURNAL OF IMAGING SCIENCE AND TECHNOLOGY
    11. Sawamura, D; Meng, XM; Ina, S; Kon, A; Tamai, K; Ohe, Y; Hashimoto, I
      Expression vector with DNA of bovine papilloma virus 1 for keratinocyte gene therapy

      JOURNAL OF DERMATOLOGICAL SCIENCE
    12. Sekine, I; Matsuda, T; Saisho, T; Watanabe, H; Yamamoto, N; Kunitoh, H; Ohe, Y; Tamura, T; Kodama, T; Saijo, N
      Bacterial meningitis observed in a phase I trial of vinorelbine, cisplatinand thoracic radiotherapy for non-small cell lung cancer: Report of a caseand discussion on dose-limiting toxicity

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    13. Fujishiro, M; Shinkai, T; Fukuda, M; Tamura, T; Ohe, Y; Kunitoh, H; Nishiwaki, Y; Sekine, I; Fukuda, H; Saijo, N
      Phase I study of a weekly infusion of irinotecan hydrochloride (CPT-11) and a 14-day continuous infusion of etoposide in patients with lung cancer: JCOG trial 9408

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    14. Okida, N; Tokumoto, M; Tokumoto, T; Nagahama, Y; Ohe, Y; Miyamoto, K; Ishikawa, K
      Cloning of cDNA encoding thimet oligopeptidase from Xenopus oocytes and regulation of the mRNA during oogenesis

      ZOOLOGICAL SCIENCE
    15. Niho, S; Nishiwaki, Y; Goto, K; Ohmatsu, H; Matsumoto, T; Hojo, F; Ohe, Y; Kakinuma, R; Kodama, T
      Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen

      LUNG CANCER
    16. Ohe, Y; Ito, H; Watanabe, N; Ichimura, K
      A novel dry photopolymer for volume-phase holograms

      JOURNAL OF APPLIED POLYMER SCIENCE
    17. Yamamoto, K; Kawai, Y; Hayashi, T; Ohe, Y; Hayashi, H; Toyoda, F; Kawahara, G; Iwata, T; Kikuyama, S
      Silefrin, a sodefrin-like pheromone in the abdominal gland of the sword-tailed newt, Cynops ensicauda

      FEBS LETTERS
    18. Ohe, Y; Kume, M; Demachi, Y; Taguchi, T; Ichimura, K
      Application of a novel photopolymer to a holographic head-up display

      POLYMERS FOR ADVANCED TECHNOLOGIES
    19. Tanaka, K; Shima, Y; Kakinuma, R; Kubota, K; Ohe, Y; Hojo, F; Matsumoto, T; Ohmatsu, H; Goto, K; Nagai, K; Nishiwaki, Y
      Effect of nebulized morphine in cancer patients with dyspnea: a pilot study

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    20. Hosomi, Y; Ohe, Y; Mito, K; Uramoto, H; Moriyama, E; Tanaka, K; Kodama, K; Niho, S; Goto, K; Ohmatsu, H; Matsumoto, T; Hojo, F; Kakinuma, R; Nishiwaka, Y
      Phase I study of cisplatin and docetaxel plus mitomycin C in patients withmetastatic non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    21. Fukumoto, H; Tamura, T; Kamiya, Y; Usuda, J; Suzuki, T; Kanzawa, F; Kuh, HJ; Ohe, Y; Saijo, N; Nishio, K
      Activation-induced apoptosis of peripheral lymphocytes treated with 7-hydroxystaurosporine, UCN-01

      INVESTIGATIONAL NEW DRUGS
    22. Suehiro, A; Imagawa, T; Hosokawa, H; Suehiro, M; Ohe, Y; Kakishita, E
      Age related elevation of serum macrophage colony stimulating factor (M-CSF) level

      ARCHIVES OF GERONTOLOGY AND GERIATRICS
    23. Fukumoto, H; Nishio, K; Ohta, S; Hanai, N; Fukuoka, K; Ohe, Y; Sugihara, K; Kodama, T; Saijo, N
      Effect of a chimeric anti-ganglioside GM2 antibody on ganglioside GM2-expressing human solid tumors in vivo

      INTERNATIONAL JOURNAL OF CANCER
    24. Ohe, Y; Kume, M; Taguchi, T; Ichimura, K
      Application of a photopolymer to a holographic reflector for reflective liquid-crystal displays

      APPLIED OPTICS
    25. KABEYA K; ISHIKAWA K; KATAKAI K; WATANABE M; OHE Y; WAKABAYASHI K; MORI M
      PROSTAGLANDIN-D-SYNTHASE (BETA-TRACE PROTEIN) LEVELS IN RAT CEREBROSPINAL-FLUID

      NeuroReport
    26. WATANABE M; OHE Y; KATAKAI K; KABEYA K; FUKUMURA Y; KOBAYASHI I; MIYAMOTO K; ISHIKAWA K
      GLUTAMINE IS INVOLVED IN THE DEPENDENCY OF BRAIN NEURON SURVIVAL ON CELL PLATING DENSITY IN CULTURE

      NeuroReport
    27. KASAI T; OHE Y; NISHIO K; KUNITOH H; TAMURA T; SEKINE I; KUBOTA K; YAMAMOTO N; NAKAMURA Y; SHINKAI T; KODAMA T; SAIJO N
      FACTORS THAT INFLUENCE THE ELIGIBILITY OF CASES FOR INCLUSION IN CLINICAL-TRIALS

      Japanese Journal of Clinical Oncology
    28. OKUSAKA T; EGUCHI K; KASAI T; KURATA T; YAMAMOTO N; OHE Y; TAMURA T; SHINKAI T; SAIJO N
      SERUM LEVELS OF PRO-GASTRIN-RELEASING PEPTIDE FOR FOLLOW-UP OF PATIENTS WITH SMALL-CELL LUNG

      Clinical cancer research
    29. KATAKAI K; SHINODA M; KABEYA K; WATANABE M; OHE Y; MORI M; ISHIKAWA K
      CHANGES IN DISTRIBUTION OF CYSTATIN-C, APOLIPOPROTEIN-E AND FERRITIN IN RAT HYPOTHALAMUS AFTER HYPOPHYSECTOMY

      Journal of neuroendocrinology
    30. FUKUMOTO H; NISHIO M; NISHIO K; HEIKE Y; ARIOKA H; KUROKAWA H; ISHIDA T; FUKUOKA K; NOMOTO T; OHE Y; SAIJO N
      INTERFERON-GAMMA-INDUCING FACTOR GENE TRANSFECTION INTO LEWIS-LUNG-CARCINOMA CELLS REDUCES TUMORIGENICITY IN-VIVO

      Japanese journal of cancer research
    31. YAMAMOTO N; TAMURA T; OHE Y; OSHITA F; KASAI T; KURATA T; SHINKAI T; EGUCHI K; SAIJO N
      CHRONOPHARMACOLOGY OF ETOPOSIDE GIVEN BY LOW-DOSE PROLONGED INFUSION IN LUNG-CANCER PATIENTS

      Anticancer research
    32. SUEHIRO A; HOSOKAWA H; HIGASA S; SUEHIRO M; OHE Y; KAKISHITA E
      AGE-RELATED AUGMENTATION OF STROKE TENDENCY EVALUATED USING PLASMA P-SELECTIN LEVELS

      Archives of gerontology and geriatrics
    33. HEIKE Y; TAKAHASHI M; OHIRA T; NARUSE I; HAMA S; OHE Y; KASAI T; FUKUMOTO H; OLSEN KJ; PODACK EE; SAIJO N
      GENETIC IMMUNOTHERAPY BY INTRAPLEURAL, INTRAPERITONEAL AND SUBCUTANEOUS INJECTION OF IL-2 GENE-MODIFIED LEWIS LUNG-CARCINOMA CELLS

      International journal of cancer
    34. ANDO M; EGUCHI K; SHINKAI T; TAMURA T; OHE Y; YAMAMOTO N; KURATA T; KASAI T; OHMATSU H; KUBOTA K; SEKINE I; HOJO N; MATSUMOTO T; KODAMA T; KAKINUMA R; NISHIWAKI Y; SAIJO N
      PHASE-I STUDY OF SEQUENTIALLY ADMINISTERED TOPOISOMERASE-I INHIBITOR (IRINOTECAN) AND TOPOISOMERASE-II INHIBITOR (ETOPOSIDE) FOR METASTATICNON-SMALL-CELL LUNG-CANCER

      British Journal of Cancer
    35. KATSUMATA N; EGUCHI K; FUKUDA M; YAMAMOTO N; OHE Y; OSHITA F; TAMURA T; SHINKAI T; SAIJO N
      SERUM LEVELS OF CYTOKINES IN PATIENTS WITH UNTREATED PRIMARY LUNG-CANCER

      Clinical cancer research
    36. ISHIMARU H; ISHIKAWA K; HAGA S; SHOJI M; OHE Y; HAGA C; SASAKI A; TAKASHASHI A; MARUYAMA Y
      ACCUMULATION OF APOLIPOPROTEIN-E AND BETA-AMYLOID-LIKE PROTEIN IN A TRACE OF THE HIPPOCAMPAL CA1 PYRAMIDAL CELL LAYER AFTER ISCHEMIC DELAYED NEURONAL DEATH

      NeuroReport
    37. SATO Y; ITOH F; HINODA Y; OHE Y; NAKAGAWA N; UEDA R; YACHI A; IMAI K
      EXPRESSION OF CD1O NEUTRAL ENDOPEPTIDASE IN NORMAL AND MALIGNANT-TISSUES OF THE HUMAN STOMACH AND COLON/

      Journal of gastroenterology
    38. PODACK ER; NISHIO M; SAVARAJ N; SPIELMAN J; CASSELITH PA; HEIKE Y; OHE Y; SAIJO N
      INDUCTION AND TARGETING OF TUMOR-SPECIFIC CTL

      Journal of clinical biochemistry and nutrition
    39. SAKURAGI T; OSHITA F; NAGASHIMA S; KASAI T; KURATA T; FUKUDA M; YAMAMOTO N; OHE Y; TAMURA T; EGUCHI K; SHINKAI T; SAIJO N
      RETROSPECTIVE ANALYSIS OF THE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER SHOWING POOR PERFORMANCE STATUS

      Japanese Journal of Clinical Oncology
    40. SAIJO N; NISHIO K; OHTA S; ARIOKA H; FUNAYAMA Y; FUKUOKA K; KUROKAWA H; NOMOTO T; ISHIDA T; YAMAMOTO N; TAMURA T; SHINKAI T; EGUCHI K; OHE Y; KUNITO H; OHTSU T; SASAKI Y
      PROGRESS IN PRECLINICAL AND CLINICAL-STUDIES FOR THE DEVELOPMENT OF NEW ANTICANCER DRUGS IN JAPAN, WITH EMPHASIS ON TAXANES

      Cancer chemotherapy and pharmacology
    41. OHIRA T; NISHIO K; OHE Y; ARIOKA H; NISHIO M; FUNAYAMA Y; OGASAWARA H; FUKUDA M; YAZAWA K; KATO H; SAIJO N
      IMPROVEMENT BY EICOSANOIDS IN CANCER CACHEXIA INDUCED BY LLC-IL6 TRANSPLANTATION

      Journal of cancer research and clinical oncology
    42. SHINODA M; OHE Y; KATAKAI K; KABEYA K; WATANABE M; MIURA T; ISHIKAWA K
      APPEARANCE OF BETA-5-MICROGLOBULIN IN RAT HYPOTHALAMIC MAGNOCELLULAR NEURONS AFTER HYPOPHYSECTOMY

      Neuroendocrinology
    43. HERZIG KH; SCHON I; TATEMOTO K; OHE Y; LI Y; FOLSCH UR; OWYANG C
      DIAZEPAM-BINDING INHIBITOR IS A POTENT CHOLECYSTOKININ RELEASING PEPTIDE IN THE INTESTINE (VOL 93, PG 7927, 1996)

      Proceedings of the National Academy of Sciences of the United Statesof America
    44. HERZIG KH; SCHON I; TATEMOTO K; OHE Y; LI Y; FOLSCH UR; OWYANG C
      DIAZEPAM-BINDING INHIBITOR IS A POTENT CHOLECYSTOKININ-RELEASING PEPTIDE IN THE INTESTINE

      Proceedings of the National Academy of Sciences of the United Statesof America
    45. OHE Y; ISHIKAWA K; ITOH Z; TATEMOTO K
      CULTURED LEPTOMENINGEAL CELLS SECRETE CEREBROSPINAL-FLUID PROTEINS

      Journal of neurochemistry
    46. OHIRA T; NISHIO K; KANZAWA F; ISHIDA T; OHE Y; ARIOKA H; FUNAYAMA Y; OGASAWARA H; KATO H; SAIJO N
      HYPERSENSITIVITY OF NIH3T3 CELLS TRANSFORMED BY H-RAS GENE TO DNA-TOPOISOMERASE-I INHIBITORS

      International journal of cancer
    47. HERZIG KH; SCHON I; TATEMOTO K; OHE Y; LI Y; FOLSCH UR; OWYANG C
      DIAZEPAM-BINDING INHIBITOR IS A CCK RELEASING PEPTIDE IN THE INTESTINE

      Gastroenterology
    48. ISHIMARU H; ISHIKAWA K; OHE Y; TAKAHASHI A; TATEMOTO K; MARUYAMA Y
      ACTIVATION OF IRON HANDLING-SYSTEM WITHIN THE GERBIL HIPPOCAMPUS AFTER CEREBRAL-ISCHEMIA

      Brain research
    49. ISHIMARU H; ISHIKAWA K; OHE Y; TAKAHASHI A; MARUYAMA Y
      CYSTATIN-C AND APOLIPOPROTEIN-E IMMUNOREACTIVITIES IN CA1 NEURONS IN ISCHEMIC GERBIL HIPPOCAMPUS

      Brain research
    50. OHE Y; ZHAO DY; SAIJO N; PODACK ER
      CONSTRUCTION OF A NOVEL BOVINE PAPILLOMAVIRUS VECTOR WITHOUT DETECTABLE TRANSFORMING ACTIVITY SUITABLE FOR GENE-TRANSFER

      Human gene therapy
    51. OSHITA F; KURATA T; KASAI T; FUKUDA M; YAMAMOTO N; OHE Y; TAMURA T; EGUCHI K; SHINKAI T; SAIJO N
      PROSPECTIVE EVALUATION OF THE FEASIBILITY OF CISPLATIN-BASED CHEMOTHERAPY FOR ELDERLY LUNG-CANCER PATIENTS WITH NORMAL ORGAN FUNCTIONS

      Japanese journal of cancer research
    52. SASAKI Y; HAKUSUI H; MIZUNO S; MORITA M; MIYA T; EGUCHI K; SHINKAI T; TAMURA T; OHE Y; SAIJO N
      A PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF CPT-11 AND ITS ACTIVE METABOLITE SN-38

      Japanese journal of cancer research
    53. SAKAI O; NODA K; OHE Y; YASAKA Y
      CONFINEMENT AND HEAT-FLUX CONTROL EXPERIMENTS IN THE HIEI TANDEM MIRROR

      Fusion technology
    54. OSHITA F; KASAI T; KURATA T; FUKUDA M; YAMAMOTO N; OHE Y; TAMURA T; EGUCHI K; SHINKAI T; SAIJO N
      INTENSIVE CHEMOTHERAPY WITH CISPLATIN, DOXORUBICIN, CYCLOPHOSPHAMIDE,ETOPOSIDE AND GRANULOCYTE-COLONY-STIMULATING FACTOR FOR ADVANCED THYMOMA OR THYMIC CANCER - PRELIMINARY-RESULTS

      Japanese Journal of Clinical Oncology
    55. YAMAMOTO N; TAMURA T; MAEDA M; ANDO M; SHINKAI T; EGUCHI K; OHE Y; OSHITA F; SHIRAISHI J; KATSUMATA N; SAIJO N
      THE INFLUENCE OF AGING ON CISPLATIN PHARMACOKINETICS IN LUNG-CANCER PATIENTS WITH NORMAL ORGAN FUNCTION

      Cancer chemotherapy and pharmacology
    56. FUKUDA M; OHE Y; KANZAWA F; OKA M; HARA K; SAIJO N
      EVALUATION OF NOVEL PLATINUM COMPLEXES, INHIBITORS OF TOPOISOMERASE-IAND TOPOISOMERASE-II IN NONSMALL CELL LUNG-CANCER (NSCLC) SUBLINES RESISTANT TO CISPLATIN

      Anticancer research
    57. SUEHIRO A; UEDA M; SUEHIRO M; OHE Y; KAKISHITA E
      EVALUATION OF PLATELET HYPERFUNCTION IN AGED SUBJECTS USING SPONTANEOUS PLATELET-AGGREGATION IN WHOLE-BLOOD

      Archives of gerontology and geriatrics
    58. NAKASHIMA H; LIEBERMAN R; KARATO A; ARIOKA H; OHMATSU H; NOMURA N; SHIRAISHI J; TAMURA T; EGUCHI K; SHINKAI T; SASAKI Y; YAMAMOTO N; HUKUDA M; OSHITA F; OHE Y; SAIJO N
      EFFICIENT SAMPLING STRATEGIES FOR FORECASTING PHARMACOKINETIC PARAMETERS OF IRINOTECAN (CPT-11) - IMPLICATION FOR AREA UNDER THE CONCENTRATION-TIME CURVE MONITORING

      Therapeutic drug monitoring
    59. MAEDA K; TANIWAKI K; SANTO T; ITSUKUMA T; ITO M; ANAN K; MISAWA M; OHE Y; KAI S; HARA H
      ANTI-A AND OR ANTI-B IS NOT DETECTABLE IN SOME PATIENTS WHO UNDERWENTABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION/

      Transfusion
    60. OSHITA F; YAMAMOTO N; FUKUDA M; OHE Y; TAMURA T; EGUCHI K; SHINKAI T; SAIJO N
      CORRELATION OF THERAPEUTIC OUTCOME IN NONSMALL CELL LUNG-CANCER AND DNA-DAMAGE ASSAYED BY POLYMERASE CHAIN-REACTION IN LEUKOCYTES DAMAGED IN-VITRO

      Cancer research
    61. ANAN K; ITO M; MISAWA M; OHE Y; KAI S; KOHSAKI M; HARA H
      CLONAL ANALYSIS OF PERIPHERAL-BLOOD AND HEMATOPOIETIC COLONIES IN PATIENTS WITH APLASTIC-ANEMIA AND REFRACTORY-ANEMIA USING THE POLYMORPHICSHORT TANDEM REPEAT ON THE HUMAN ANDROGEN-RECEPTOR (HUMARA) GENE

      British Journal of Haematology
    62. ISHIKAWA K; OHE Y; TATEMOTO K
      SYNTHESIS AND SECRETION OF INSULIN-LIKE GROWTH-FACTOR (IGF)-II AND IGF BINDING PROTEIN-2 BY CULTIVATED BRAIN MENINGEAL CELLS

      Brain research
    63. SUZUKI S; OHE Y; OKUBO T; KAKEGAWA T; TATEMOTO K
      ISOLATION AND CHARACTERIZATION OF NOVEL ANTIMICROBIAL PEPTIDES, RUGOSIN-A, RUGOSIN-B AND RUGOSIN-C, FROM THE SKIN OF THE FROG, RANA-RUGOSA

      Biochemical and biophysical research communications
    64. OHIRA T; OHE Y; HEIKE Y; PODACK ER; OLSEN KJ; NISHIO K; NISHIO M; MIYAHARA Y; FUNAYAMA Y; OGASAWARA H; ARIOKA H; KATO H; SAIJO N
      GENE-THERAPY FOR LEWIS LUNG-CARCINOMA WITH TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-2 CDNAS CO-TRANSFECTED SUBLINE

      Gene therapy
    65. EGUCHI K; ETOU H; MIYACHI S; MORINARI H; NAKADA K; NODA K; OHKUNI Y; WATANABE K; YAMADA Y; OHE Y; TAMURA T; SASAKI Y; SHINKAI T; SAIJO N
      STUDY OF DOSE-ESCALATION OF TENIPOSIDE (VM-26) PLUS CISPLATIN (CDDP) WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF)IN PATIENTS WITH ADVANCED SMALL-CELL LUNG-CANCER

      European journal of cancer
    66. MATSUMURA T; LI DX; KWON YS; HAGA Y; OHE Y; SHIDA H; SUZUKI T
      IMPURITY-INDUCED PROPERTIES OF CONDUCTING TMTE

      Physica. B, Condensed matter
    67. YAMAMOTO N; TAMURA T; KARATO A; UENAKA K; EGUCHI K; SHINKAI T; OHE Y; OSHITA F; ARIOKA H; NAKASHIMA H; SHIRAISHI J; FUKUDA M; HIGUCHI S; SAIJO N
      CPT-11 - POPULATION PHARMACOKINETIC MODEL AND ESTIMATION OF PHARMACOKINETICS USING THE BAYESIAN METHOD IN PATIENTS WITH LUNG-CANCER

      Japanese journal of cancer research
    68. OHE Y; HINODA Y; IRIMURA T; IMAI K; YACHI A
      EXPRESSION OF SULFATED CARBOHYDRATE CHAINS DETECTED BY MONOCLONAL-ANTIBODY 91.9H IN HUMAN GASTRIC-CANCER TISSUES

      Japanese journal of cancer research
    69. OHMATSU H; EGUCHI K; SHINKAI T; TAMURA T; OHE Y; NISIO M; KUNIKANE H; ARIOKA H; KARATO A; NAKASHIMA H; SASAKI Y; TAJIMA K; TADA N; SAIJO N
      A RANDOMIZED CROSS-OVER STUDY OF HIGH-DOSE METOCLOPRAMIDE PLUS DEXAMETHASONE VERSUS GRANISETRON PLUS DEXAMETHASONE IN PATIENTS RECEIVING CHEMOTHERAPY WITH HIGH-DOSE CISPLATIN

      Japanese journal of cancer research
    70. TAMURA T; SASAKI Y; EGUCHI K; SHINKAI T; OHE Y; NISHIO M; KUNIKANE H; ARIOKA H; KARATO A; OMATSU H; NAKASHIMA H; SAIJO N
      PHASE-I AND PHARMACOKINETIC STUDY OF PACLITAXEL BY 24-HOUR INTRAVENOUS-INFUSION

      Japanese journal of cancer research
    71. IMAI K; IBAYASHI Y; HIGASHIDE T; OHE Y; TOYOTA M; SAKAMOTO SI; SUGIYAMA T; TSUJISAKI M; UNE Y; UCHINO JI; HINODA Y; SUGA M; YACHI A
      DETECTION OF MESSENGER-RNA OF ALPHA-FETOPROTEIN IN TISSUES OF LIVER-CIRRHOSIS, CHRONIC HEPATITIS AND OF HEPATOCELLULAR-CARCINOMA

      Journal of tumor marker oncology
    72. ISHIHARA K; NAGAKURA T; MASUDA W; OKADA T; OHE Y; KISHIMOTO S; NOSAKA K; HAYASHI T; ASAO M; FURUKAWA T
      COLORED 2-D BLOOD-FLOW STRUCTURE ON B-MODE ECHOGRAPHY USING 2-DIMENSIONAL MOVING TARGET INDICATION

      Journal of the American College of Cardiology
    73. ISHIHARA K; NAGAKURA T; MASUDA K; OKADA T; OHE Y; KISHIMOTO S; NOSAKA K; HAYASHI T; ASAO M; FURUKAWA T
      COLOR VISUALIZATION OF PROPAGATING CONTRACTION FROM THE FOCUS OF VENTRICULAR PREMATURE CONTRACTION BY HIGH-SPEED DIGITAL SUBTRACTION ECHOGRAPHY

      Journal of the American College of Cardiology
    74. KOGA H; EGUCHI K; SHINKAI T; TAMURA T; OHE Y; OSHITA F; SAIJO N; KONDO H; OKI K; OKURA H
      PRELIMINARY EVALUATION OF THE NEW TUMOR-MARKER, CYFRA-21-1, IN LUNG-CANCER PATIENTS

      Japanese Journal of Clinical Oncology
    75. SAIJO N; NISHIO K; KUBOTA N; KANZAWA F; SHINKAI T; KARATO A; SASAKI Y; EGUCHI K; TAMURA T; OHE Y; OSHITA F; NISHIO M
      7-ETHYL-10-[4-(1-PIPERIDINO)-1-PIPERIDINO] CARBONYLOXY CAMPTOTHECIN -MECHANISM OF RESISTANCE AND CLINICAL-TRIALS

      Cancer chemotherapy and pharmacology
    76. KOJIMA A; SHINKAI T; SOEJIMA Y; OKAMOTO H; EGUCHI K; SASAKI Y; TAMURA T; OSHITA F; OHE Y; SAIJO N
      A RANDOMIZED PROSPECTIVE-STUDY OF IMIPENEM-CILASTATIN WITH OR WITHOUTAMIKACIN AS AN EMPIRICAL ANTIBIOTIC-TREATMENT FOR FEBRILE NEUTROPENICPATIENTS

      American journal of clinical oncology
    77. SHINKAI T; TAMURA T; SANO T; KOJIMA A; EGUCHI K; SASAKI Y; OHE Y; SAIJO N
      IN-VITRO AND IN-VIVO CYTOGENETIC EFFECTS OF RECOMBINANT INTERLEUKIN-2ON HUMAN-LYMPHOCYTES

      American journal of clinical oncology
    78. SUGA H; SENOTA A; ARIMA K; KODAMA T; IKUTA S; SAKAMOTO H; OHE Y; SUGAI S; YACHI A
      PREVALENCE OF HBV AND HCV INFECTION IN JAPANESE PATIENTS WITH HEPATOCELLULAR-CARCINOMA

      Hepato-gastroenterology
    79. OHIRA T; OHE Y; HEIKE Y; PODACK ER; OLSEN KJ; NISHIO F; NISHIO M; MIYAHARA Y; FUNAYAMA Y; OGASAWARA H; ARIOKA H; KUNIKANE H; FUKUDA M; KATO H; SAIJO N
      IN-VITRO AND IN-VIVO GROWTH OF B16F10 MELANOMA-CELLS TRANSFECTED WITHINTERLEUKIN-4 CDNA AND GENE-THERAPY WITH THE TRANSFECTANT

      Journal of cancer research and clinical oncology
    80. SAIJO N; EGUCHI K; ETOU H; MIYACHI S; MORINARI H; NAKADA K; NODA K; OHKUNI Y; WATANABE K; YAMADA Y; KABE J; KUDO S; MANO K; MORINARI H; TANAKA T; UZAWA T; OHE Y; TAMURA T; SASAKI Y; SHINKAI T
      THE ROLE OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN CHEMOTHERAPY FOR LUNG-CANCER

      Seminars in oncology
    81. KATAOKA T; OHE Y; UMEDA A; IWAMURA T; YOSHIMATSU M; SHIMIZU H
      GENERATION OF SELENABENZENES BEARING AN ELECTRON-WITHDRAWING GROUP ATTHE 2-POSITION

      Chemical and Pharmaceutical Bulletin
    82. SHINKAI T; ARIOKA H; KUNIKANE H; EGUCHI K; SASAKI Y; TAMURA T; OHE Y; OSHITA F; NISHIO M; KARATO A; OKAMOTO H; NAKASHIMA H; OHMATSU H; SHIRAISHI J; NOMURA N; SAIJO N
      PHASE-I CLINICAL-TRIAL OF IRINOTECAN (CPT-11), PIPERIDINO)-1-PIPERIDINO]CARBONYLOXY-CAMPTOTHECIN, AND CISPLATIN IN COMBINATION WITH FIXED-DOSE OF VINDESINE IN ADVANCED NONSMALL CELL LUNG-CANCER

      Cancer research
    83. OHE Y; ICHIMURA K
      POSITIVE-WORKING PHOTORESISTS SENSITIVE TO VISIBLE-LIGHT .3. POLY(TETRAHYDROPYRANYL METHACRYLATES) ACTIVATED BY DYE-SENSITIZED DECOMPOSITION OF DIPHENYLIODONIUM SALT

      Journal of imaging science and technology
    84. OHE Y; IWATA F; ICHIMURA K
      POSITIVE-WORKING PHOTORESIST CONTAINING TETRAHYDROPYRANYL GROUPS AS AN ACID-LABILE POLYMER FOR RELIEF HOLOGRAMS

      Journal of imaging science and technology
    85. OHE Y; OHTANI K; SONE Y; MISAKI A
      GLYCOSYLATION AND CHARACTERIZATION OF HUMAN EPIDERMAL GROWTH-FACTOR

      Bioscience, biotechnology, and biochemistry
    86. KARATO A; SASAKI Y; SHINKAI T; EGUCHI K; TAMURA T; OHE Y; OSHITA F; NISHIO M; KUNIKANE H; ARIOKA H; OHMATSU H; NAKASHIMA H; SHIRAISHI J; SAIJO N
      PHASE-I STUDY OF CPT-11 AND ETOPOSIDE IN PATIENTS WITH REFRACTORY SOLID TUMORS

      Journal of clinical oncology
    87. OHE Y; PODACK ER; OLSEN KJ; MIYAHARA Y; MIURA K; SAITO H; KOISHIHARA Y; OHSUGI Y; OHIRA T; NISHIO K; SAIJO N
      INTERLEUKIN-6 CDNA TRANSFECTED LEWIS LUNG-CARCINOMA CELLS SHOW UNALTERED NET TUMOR-GROWTH RATE BUT CAUSE WEIGHT-LOSS AND SHORTEN SURVIVAL IN SYNGENIC MICE

      British Journal of Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 22:58:33